Skip to main content
logo
Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
6.04
+0.39 (6.90%)
At close: May 20, 2026, 4:00 PM EDT
6.16
+0.12 (1.99%)
After-hours: May 20, 2026, 4:41 PM EDT

Entrada Therapeutics Revenue

Entrada Therapeutics had revenue of $875.00K in the quarter ending March 31, 2026, a decrease of -95.74%. This brings the company's revenue in the last twelve months to $5.74M, down -96.67% year-over-year. In the year 2025, Entrada Therapeutics had annual revenue of $25.42M, down -87.94%.

Revenue (ttm)
$5.74M
Revenue Growth
-96.67%
P/S Ratio
36.74
Revenue / Employee
$37,750
Employees
152
Market Cap
217.64M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202525.42M-185.36M-87.94%
Dec 31, 2024210.78M81.77M63.38%
Dec 31, 2023129.01M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Atrium Therapeutics36.68M
Voyager Therapeutics36.49M
Keros Therapeutics33.18M
LENZ Therapeutics20.99M
Sol-Gel Technologies19.39M
MediWound16.96M
Adagene7.67M
Fate Therapeutics6.32M
Revenue Rankings

TRDA News

More News